Ropes & Gray represented Avista Capital Partners and its portfolio company United BioSource LLC (UBC), a biopharmaceutical services provider, in its acquisition of Examoto, LLC, a Risk Evaluation and Mitigation Strategy (REMS) company. Terms of the transaction were not disclosed. The deal was announced on July 28 in a press release.
Examoto is a leader in FDA-mandated REMS compliance platforms addressing safer pharmaceutical outcomes. UBC provides integrated clinical, safety, and commercialization services to the biopharmaceutical market. Avista Capital Partners is a New York-based private equity firm that has invested nearly $8 billion in 40 growth-oriented healthcare businesses around the world.
The Ropes & Gray team that represented Avista Capital was led by private equity partner Bob Rivollier and senior associate Sam Levitt, and included employment, executive compensation & benefits partner Danna Kivell, health care partner Devin Cohen, FDA regulatory partner Kellie Combs, finance partner Arek Maczka, and tax partner Benjamin Rogers.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.